MacroGenics, Inc. (MGNX) vs Niagen Bioscience Inc (NAGE)

A side-by-side comparison of MacroGenics, Inc. and Niagen Bioscience Inc across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — MGNX vs NAGE

growth of $100 · dividends reinvested · last 10y
MGNX -87.5% (-18.7%/yr)NAGE -10.1% (-1.1%/yr)NAGE compounded faster over this window
Log scale — wide-divergence pair
1101001kStart $10020182020202220242026$13$90
MGNX NAGE

MGNX vs NAGE: by the numbers

  • •MGNX is the larger company ($231M vs $214M market cap).
  • •NAGE is profitable (12.39% net margin) while MGNX runs a net loss (-8.70%).
  • •NAGE grew revenue faster over the past five years (15.80% vs 7.33% CAGR).

Metrics side by side

Valuation

MetricMGNXNAGE
P/E ratioN/A14.43
Forward P/EN/A18.65
P/S ratio1.381.66
P/B ratio5.402.60
EV / EBITDAN/A14.36
FCF yieldN/A2.65%

Profitability

MetricMGNXNAGE
Gross margin71.12%64.24%
Operating margin-48.72%6.67%
Net margin-8.70%12.39%
ROE-34.04%19.38%
ROIC-16.87%8.84%

Growth (annualized)

MetricMGNXNAGE
Revenue CAGR (5Y)7.33%15.80%
Total return CAGR (5Y)-28.42%-15.72%

Frequently asked

Which has grown faster, MGNX or NAGE?
Over the past five years, NAGE grew revenue faster — MGNX at a 7.33% CAGR versus NAGE at 15.80%.
Is MGNX or NAGE more profitable?
NAGE runs the higher net margin — MGNX at -8.70% versus NAGE at 12.39%.
How have MGNX and NAGE total returns compared?
Over the past 10 years, MGNX delivered -18.75% and NAGE delivered -1.06% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.